Stefan Barta, MD, discusses the heterogeneity of T-cell lymphoma, highlighting that a one-size-fits-all approach is ineffective and emphasizing the need for tailored treatment approaches.
Stefan Barta, MD
Stefan Barta, MD, is an associate professor of clinical medicine and director of the T-cell lymphoma program, University of Pennsylvania Department of Medicine.
Articles by Stefan Barta, MD
Latest Updated Articles
Breaking Down the Barriers to Effective T-Cell Lymphoma TreatmentSeptember 4th 2024